Papillary microcarcinoma of the thyroid gland

British Journal of Surgery

Volumn 83, Issue 12, 1996, Pages 1674-1683

  Bramley, M D ^a   Harrison, B J ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROXINE;

HUMAN; PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID GLAND; THYROID PAPILLARY CARCINOMA;

EID: 0029731150     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800831206     Document Type: Review

References (93)

1. Office of Population Censuses and Surveys. 1991 Mortality Statistics, Cause. England and Wales. Series DH2 no. 18. London: HMSO, 1993: 1-17.
2. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986; 61: 978-96.
3. Rosai J, Zampi G, Carcangiu ML. Papillary carcinoma of the thyroid, a discussion of its several morphologic expressions, with particular emphasis on the follicular variant. Am J Surg Pathol 1983; 7: 809-17.
4. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 414-24.
5. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981; 70: 511-18.
6. Woolner LB, Lemmon ML, Beahrs OH, Black BM, Keating FR. Occult papillary carcinoma of the thyroid gland: a study of 140 cases observed in a 30 year period. J Clin Endocrinol 1960; 20: 89-105.
7. Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki. Prevalence of thyroid carcinoma at autopsy. JAMA 1969; 209: 65-70.
8. Sampson RJ, Oka H, Key CR, Buncher CR, Iijima S. Metastases from occult thyroid carcinoma, an autopsy study from Hiroshima and Nagasaki. Cancer 1970; 25: 803-11.
9. Fukunaga FH, Lockett LJ. Thyroid carcinoma in the Japanese in Hawaii. Arch Pathol 1971; 92: 6-13.
10. Sampson RJ, Woolner LB, Bahn RC, Kurland LT. Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 1974; 34: 2072-6.
11. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975; 36: 1095-9.
12. Sobrinho-Simões MA, Sambade MC, Gonçalves V. Latent thyroid carcinoma at autopsy. A study from Oporto, Portugal. Cancer 1979; 43: 1702-6.
13. Bondeson L, Ljungherg O. Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer 1981; 47: 319-23.
14. Bondeson L, Ljungherg O. Occult papillary thyroid carcinoma in the young and the aged. Cancer 1984; 53: 1790-2.
15. Harach HR, Franssila KO, Wasenius V. Occult papillary carcinoma of the thyroid, a 'normal' finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531-8.
16. Franssila KO, Harach HR. Occult papillary carcinoma of the thyroid in children and young adults. A systematic autopsy study in Finland. Cancer 1986; 58: 715-19.
17. Arellano L, Ibarro A. Occult carcinoma of the thyroid gland. Pathol Res Pract 1984; 179: 88-91.
18. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol 1988; 90: 72-6.
19. Ottino A, Pianozola HM, Castelletto RH. Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer 1989; 64: 547-51.
20. Bisi H, Fernandes VSO, Asato de Camargo RY et al. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer 1989; 64: 1888-93.
21. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990; 65: 1173-9.
22. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Caravilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 1993; 71: 4022-9.
23. Furmanchuk AW, Roussak N, Ruchti C. Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy of 215 patients. Histopathology 1993; 23: 319-25.
24. Delides GS. Elemenoglu J, Lekkas J, Kittas CH, Evthimiou C. Occult thyroid carcinoma in a Greek population. Neoplasma 1987; 34: 119-25.
25. Welbourn RB, Johnston IDA. Thyroid cancer. In: Welbourn RB, ed. The History of Endocrine Surgery. New York: Praeger, 1990: 64-70.
26. Schrager VL. Lateral aberrant thyroids. Surg Gynecol Obstet 1906; 3: 465-75.
27. Frantz VK, Forsythe R, Hanford JM, Rogers WM. Lateral aberrant thyroids. Ann Surg 1942; 115: 161-83.
28. King WM, Pemberton J de J. So called lateral aberrant tumors. Surg Gynecol Obstet 1942; 74: 991-1001.
29. Eberts EM. Lateral cervical aberrant thyroid. Can Med Assoc J 1933; 29: 32-3.
30. Black BM. Papillary adenocarcinoma of the thyroid gland, socalled lateral aberrant thyroid. Western Journal of Surgery 1948; 56: 134-44.
31. Wozencraft P, Foote FW, Frazell EL. Occult carcinomas of the thyroid. Their bearing on the concept of lateral aberrant thyroid cancer. Cancer 1948; 1: 574-83.
32. Hay ID, Grant CS, van Heerden JA et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50 year period. Surgery 1992; 112: 1139-47.
33. Hedinger C, Williams ED, Sobin LH. Histological typing, of thyroid tumours. In: WHO International Histological Classification of Tumours. 2nd ed. Berlin: Springer, 1988: 9-11.
34. Chan JKC. Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 1990; 5: 241-57.
35. Kasai N, Sakamoto A. New subgrouping of small thyroid carcinomas. Cancer 1987; 60: 1767-70.
36. Williams ED, Doniach I, Bjarnason O, Michi W. Thyroid cancer in an iodine rich area. A histopathological study. Cancer 1977; 79: 215-22.
37. Harach HR, Escalante DA, Onativia A et al. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol 1985; 108: 55-60.
38. Olen E, Klinck GH. Hyperthyroidism and thyroid cancer. Arch Pathol 1966; 81: 531-5.
39. Yeo PPB, Wang KW, Sinniah R et al. Thyrotoxicosis and thyroid cancer. Aust N Z J Med 1982; 12: 589-93.
40. Park SH, Suh EH, Chi JG. A histopathologic study on 1095 surgically resected thyroid specimens. Jpn J Clin Oncol 1988; 18: 297-302.
41. Pelizzo MR, Piotto A, Rubello D et al. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 1990; 76: 255-7.
42. Ahuja S, Ernst H. Hyperthyroidism and thyroid carcinoma. Acta Endocrinol 1991; 124: 146-51.
43. Terzioglu T, Tezelman S, Onaran Y, Tanakol R. Concurrent hyperthyroidism and thyroid carcinoma. Br J Surg 1993; 80: 1301-2.
44. Kasuga Y, Sugenoya A, Kobayashi S, Masuda H, lida F. The outcome of patients with thyroid carcinoma and Graves' disease. Jpn J Surg 1993; 23: 9-12.
45. Farbota LM, Calandra DB, Lawrence AM. Paloyan E. Thyroid carcinoma in Graves' disease. Surgery 1985; 98: 1148-52.
46. Bielschowsky F. Neoplasm and internal environment. Br J Cancer 1955; 9: 80-116.
47. Filetti S, Belfiore A, Amir S et al. The role of thyroidstimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 1988; 318: 753-9.
48. Duffy GJ Jr, Fitzgerald PJ. Thyroid cancer in childhood and adolescence. Cancer 1950; 3: 1018.
49. Wagner DH, Recant WM, Evans RH. A review of one hundred and fifty thyroidectomies following prior irradiation to the head, neck and upper part of the chest. Surg Gynecol Obstet 1978; 147: 903-8.
50. Hubert JP, Kiernan PD, Bearhrs OH, McConahey WM, Woolner LB. Occult papillary carcinoma of the thyroid. Arch Surg 1980; 115: 394-8.
51. Ardito G, Cavallaro A, Mantovani M et al. Occult carcinoma of the thyroid, a changing pathology? J R Coll Surg Edinb 1982; 27: 219-23.
52. Noguchi S, Yamashita H, Murakami N et al. Small carcinomas of the thyroid - a long-term follow-up of 867 patients. Arch Surg 1996; 131: 187-91
53. Griffith GH. Cystic metastasis from an occult papillary carcinoma of the thyroid gland. Br J Surg 1966; 53: 816-18.
54. Levy I, Barki Y, Tovi F. Cystic metastases of the neck from occult thyroid adenocarcinoma. Am J Surg 1992; 163: 298-300.
55. Levy I, Barki Y, Tovi F. Giant cervical cyst: presenting symptom of an occult thyroid carcinoma. J Laryngol Otol 1991; 105: 863-4.
56. Loughran CF. Case report: cystic lymph node metastasis from occult thyroid carcinoma: sonographic mimic of a branchial cleft cyst. Clin Radiol 1991; 43: 213-14.
57. Hwang CF, Wu CM, Su CY, Cheng L. View from beneath - pathology in focus. A long-standing cystic lymph node metastasis from occult thyroid carcinoma - report of a case. J Laryngol Otol 1992; 106: 932-4.
58. Gikas PW, Labow SS, DiGuilio W et al. Occult metastasis from occult papillary carcinoma of the thyroid. Cancer 1967; 20: 2100-4.
59. Patchefsky AS, Keller IB, Mansfield CM. Solitary vertebral column metastasis from occult sclerosing carcinoma of the thyroid gland. Am J Clin Pathol 1970; 53: 596-601.
60. Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer 1984; 54: 1093-100.
61. Lloyd RV, Beierwaltes WH. Occult sclerosing carcinoma of the thyroid: potential for aggressive biologic behavior. South Med J 1983; 76: 437-9.
62. Harach HR, Franssila KO. Occult papillary carcinoma of the thyroid appearing as lung metastasis. Arch Pathol Lab Med 1984; 108: 529 (Letter).
63. Allo MD, Christiansen W, Koivunen D. Not all 'occult' papillary carcinomas are 'minimal'. Surgery 1988; 104: 971-6.
64. Salvadori B, Del Bo R, Pilotti S, Grassi M, Cusumano F. 'Occult' papillary carcinoma of the thyroid: a questionable entity. Eur J Cancer 1993; 29A: 1817-20.
65. Witterick IJ, Abel SM, Noyek AM, Freeman JL, Chapnik JS. Nonpalpable occult and metastatic papillary thyroid carcinoma. Laryngoscope 1993; 103: 149-55.
66. Rosen IB, Abbas A, Walfish PG et al. Ultrasound-guided fine-needle aspiration biopsy in the management of thyroid disease. Am J Surg 1993; 166: 346-9.
67. Takami H, Kodaira S. A rapid immunoperoxidase method for pathological diagnosis of occult thyroid carcinoma. Int Surg 1993; 78: 225-8.
68. Yagi Y, Shunichi Y, Saku T. The localization of cytoskeletal proteins and thyroglobulin in thyroid microcarcinoma in comparison with clinically manifested thyroid carcinoma. Cancer 1985; 56: 1967-71.
69. Yamamoto Y, Izumi K, Otsuka H. An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Cancer 1992; 70: 2326-33.
70. Buckwalter JA, Thomas CG. Selection of surgical treatment tor well differentiated thyroid carcinomas. Ann Surg 1972; 176: 565-77.
71. Frauenhoffer CM, Patchefsky AS, Cobanoglu A. Thyroid carcinoma, a clinical and pathologic study of 125 cases. Cancer 1979; 43: 2414-21.
72. Ito J, Noguchi S, Murakami N, Noguchi A. Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 1980; 150: 539-44.
73. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 805-28.
74. Biersack HJ, Helpap B, Koch U et al. Should treatment of highly differentiated thyroid carcinoma be conservative? Nuclear Medicine 1983; 22: 20-3.
75. Jacobs JK, Aland JW Jr, Balinger JF. Total thyroidectomy. A review of 213 patients. Ann Surg 1983; 197: 542-8.
76. Clark OH. Total thyroidectomy. The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196: 361-8.
77. Starnes HF, Brooks DC, Pinkus GS, Brooks JR. Surgery for thyroid carcinoma. Cancer 1985; 55: 1376-81.
78. Vickery AL, Wang C, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987; 60: 2587-95.
79. Grant CS, Hay ID, Gough IR et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988; 104: 954-62.
80. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978; 136: 107-12.
81. Christensen SB, Ljungberg O, Tibblin S. Thyroid carcinoma in Malmö, 1960-77. Epidemiologic, clinical, and prognostic findings in a defined urban population. Cancer 1984; 53: 1625-33.
82. Christensen SB, Ljungberg O, Tibblin S. A clinical epidemiologic study of thyroid carcinoma in Malmö. Sweden. Curr Probal Cancer 1984; 8: 1-49.
83. Rustad WH, Lindsay S, Dailey MF. Comparison of the incidence of complications following total and subtotal thyroidectomy for thyroid carcinoma. Surg Gynecol Obstet 1963; 116: 109-12.
84. Foster RS. Morbidity and mortality after thyroidectomy. Surg Gynecol Obstet 1978; 146: 423-9.
85. Attic JN, Moskowitz GW, Margouleff D, Levy LM. Feasibility of total thyroidectomy in the treatment of thyroid carcinoma. Am J Surg 1979; 138: 555-60.
86. Beahrs OH, Vandertoll DJ. Complications of secondary thyroidectomy. Surg Gynecol Obstet 1963; 117: 535-9.
87. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102: 1088-95.
88. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104: 947-53.
89. Pasieka JL, Zedenius J, Auer G et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992; 112: 1154-60.
90. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050-8.
91. Block MA. Surgical progress. Management of carcinoma of the thyroid. Ann Surg 1977; 185: 133-44.
92. Reed RJ, Russin DJ, Krementz ET. Latent metastases from occult sclerosing carcinoma of the thyroid. JAMA 1966; 196: 143-5.
93. Sanders LE, Rossi R. Occult well differentiated thyroid carcinoma presenting as cervical node disease. World J Surg 1995; 19: 642-7.